Table 1.
Annual Reported Cases of Neonatal Tetanus and TT2 Coverage From 2009 to 2013 for Countries Completing Countrywide PsA-TT Campaigns in Persons Aged 1–29 Years by 2012
| Country | Year of PsA-TT Campaign | 2009 |
2010 |
2011 |
2012 |
2013 |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NT Cases | NT Coverage Estimate, % | NT Cases | NT Coverage Estimate, % | NT Cases | NT Coverage Estimate, % | NT Cases | NT Coverage Estimate, % | NT Cases | NT Coverage Estimate, % | ||
| Burkina Faso | 2010 | 6 | 85 | 2 | 85 | 2 | 88 | 1 | 88 | 0 | 88 |
| Mali | 2010–2011 | 13 | 92 | 7 | 85 | 11 | 89 | 10 | 89 | 12 | 85 |
| Niger | 2010–2011 | 14 | 84 | 13 | 84 | 11 | 84 | 3 | 84 | 1 | 81 |
| Gambia | 2011 | 0 | 91 | 0 | 91 | 2 | 91 | 0 | 92 | 0 | 82 |
| Chad | 2012 | 146 | 60 | 279 | 60 | 215 | 60 | 225 | 43 | 176 | 50 |
| Senegal | 2012 | 16 | 88 | 12 | 88 | 21 | 88 | 14 | 91 | 4 | 91 |
| Total | 195 | 313 | 260 | 253 | 193 | ||||||
Post–PsA-TT campaign data are shown in bold.
Abbreviations: NT, neonatal tetanus; PsA-TT, group A meningococcal conjugate vaccine; TT2, second dose of tetanus toxoid.